MR Guided Focused Ultrasound Surgery
MR 引导聚焦超声手术
基本信息
- 批准号:7255003
- 负责人:
- 金额:$ 19.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
During the current funded period of this research, we have successfully implemented MRI-based
thermometry for the monitoring of focused ultrasound treatments. We have used MRI-based thermometry to
determine the threshold thermal dose for tissue damage during short sonications, and we have
demonstrated its usefulness in a clinical setting in treatments of breast fibroadenomas, breast cancer, and
uterine fibroids. We have also developed methods for treatment planning and shown the impact of wavefront
distortion by overlying tissues. Based on these results, we propose to further this research by testing the
following hypothesis: Intracavitary ultrasound phased arrays can be used to effectively coagulate prostate
tumors when MRI temperature monitoring is used. To test this hypothesis we will first, explore the feasibility
of using intracavitary focused ultrasound phased arrays with MRI monitoring by developing a linear array
system for minimally invasive ultrasound surgery of early stage prostate cancer and performing pre-clinical
tests of it in an animal model. Second, we will explore methods to use MRI derived temperature information
to control the treatment so that the coagulation of the complete target volume can be accomplished. Finally,
we will develop full-scale two-dimensional transrectal arrays that will exploit the full potential of phased array
ultrasound technology for the treatment of prostate disease. At the close of this research we will have
developed the necessary methods for clinical feasibility testing of a precise and monitored thermal
coagulation method for prostate cancer that can reduce both the treatment time and the impotency rate. This
procedure may replace current open surgery with a method that could potentially be performed on outpatient
basis and is much less invasive. The healthcare benefits of the proposed treatments are significant and
include faster recovery, reduced cost, and a lowered risk of infection and bleeding
在本研究的当前资助期间,我们成功地实施了基于MRI的
用于监测聚焦超声处理的温度计。我们已经使用基于MRI的热法
确定在短超声音期间组织损伤的阈值热剂量,我们有
在乳腺纤维纤维瘤,乳腺癌和
子宫肌瘤。我们还开发了治疗计划的方法,并显示了波前的影响
通过覆盖组织的变形。基于这些结果,我们建议通过测试
以下假设:卫星内超声段阵列可用于有效凝结前列腺
使用MRI温度监测时的肿瘤。为了检验这一假设,我们将首先探索可行性
通过开发线性阵列,使用带有腔内聚焦的超声段阵列和MRI监测
早期前列腺癌的最小侵入性超声手术的系统并进行临床前进行
在动物模型中对其进行测试。其次,我们将探索使用MRI派生温度信息的方法
为了控制治疗,以便可以完成完整目标体积的凝结。最后,
我们将开发全尺度的二维转直肠阵列,这些阵列将利用分阶段阵列的全部潜力
用于治疗前列腺疾病的超声技术。在这项研究结束时,我们将拥有
开发了精确和监测热的临床可行性测试的必要方法
前列腺癌的凝结方法可以降低治疗时间和阳ot的率。这
手术可以用一种可能在门诊病人上执行的方法代替当前的开放手术
基础,侵入性要小得多。拟议治疗的医疗保健益处很重要,并且
包括更快的恢复速度,降低的成本以及降低感染风险和出血的风险
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Kullervo Hynynen的其他基金
MR Guided Focused Ultrasound Surgery
MR 引导聚焦超声手术
- 批准号:82863588286358
- 财政年份:2011
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
OPENING THE BLOOD BRAIN BARRIER FOR MOLECULAR IMAGING
打开血脑屏障进行分子成像
- 批准号:79608687960868
- 财政年份:2009
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments
用于中风治疗的新型超声相控阵和超声处理方法
- 批准号:76902247690224
- 财政年份:2008
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
OPENING THE BLOOD BRAIN BARRIER FOR MOLECULAR IMAGING
打开血脑屏障进行分子成像
- 批准号:77196567719656
- 财政年份:2008
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments
用于中风治疗的新型超声相控阵和超声处理方法
- 批准号:79220227922022
- 财政年份:2008
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments
用于中风治疗的新型超声相控阵和超声处理方法
- 批准号:83192198319219
- 财政年份:2008
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments
用于中风治疗的新型超声相控阵和超声处理方法
- 批准号:81234278123427
- 财政年份:2008
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
A Novel Ultrasound Phased Array and Sonication Method for Stroke Treatments
用于中风治疗的新型超声相控阵和超声处理方法
- 批准号:75597727559772
- 财政年份:2008
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
ULTRASOUND THERAPY DELIVERY THROUGH INTACT SKULL
通过完整的颅骨进行超声治疗
- 批准号:75636787563678
- 财政年份:2007
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
OPENING THE BLOOD BRAIN BARRIER FOR MOLECULAR IMAGING
打开血脑屏障进行分子成像
- 批准号:75636777563677
- 财政年份:2007
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
癌症免疫治疗中抗原和 T 细胞运输的系统生物学
- 批准号:1075119210751192
- 财政年份:2023
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
High-resolution 3D in situ Spatial Gene Expression Profiling Technology for Human Brain Specimens
人脑标本高分辨率3D原位空间基因表达谱分析技术
- 批准号:1038507210385072
- 财政年份:2022
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
Humanized anti-CXCL1 antibody for bladder cancer therapeutics
用于膀胱癌治疗的人源化抗 CXCL1 抗体
- 批准号:1029023710290237
- 财政年份:2021
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
Humanized anti-CXCL1 antibody for bladder cancer therapeutics
用于膀胱癌治疗的人源化抗 CXCL1 抗体
- 批准号:1045442210454422
- 财政年份:2021
- 资助金额:$ 19.8万$ 19.8万
- 项目类别:
TP53 Germline Mutations: Beyond LFS
TP53 种系突变:超越 LFS
- 批准号:99121169912116
- 财政年份:2019
- 资助金额:$ 19.8万$ 19.8万
- 项目类别: